TickerFacts.

Iqvia Holdings Inc. (IQV): Operating Income

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$2.18B
Year ended 2025-12-31
$2.20B
Trailing 12 months to 2026-03-31
+6.6%
3-year compound annual growth
+24.4%
5-year compound annual growth
$2.20B2011-12-31: $345.25M2012-12-31: $396.44M2013-12-31: $462.33M2014-12-31: $590.00M2015-12-31: $646.00M2016-12-31: $576.00M2017-12-31: $665.00M2018-12-31: $741.00M2019-12-31: $777.00M2020-12-31: $731.00M2021-12-31: $1.39B2022-12-31: $1.80B2023-12-31: $1.98B2024-12-31: $2.20B2025-12-31: $2.18B$2.18B
2011-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31$2.18B-0.9%2026-02-17, From 2025-01-01
2024-12-31$2.20B+11.4%2026-02-17, From 2024-01-01
2023-12-31$1.98B+9.9%2026-02-17, From 2023-01-01
2022-12-31$1.80B+29.1%2025-02-13, From 2022-01-01
2021-12-31$1.39B+90.6%2024-02-15, From 2021-01-01
2020-12-31$731.00M-5.9%2023-02-15, From 2020-01-01
2019-12-31$777.00M+4.9%2022-02-16, From 2019-01-01
2018-12-31$741.00M+11.4%2021-02-12, From 2018-01-01
2017-12-31$665.00M+15.5%2020-02-18, From 2017-01-01
2016-12-31$576.00Mn/c2019-02-19, From 2016-01-01
2015-12-31$646.00M+9.5%2018-02-16, From 2015-01-01
2014-12-31$590.00M+27.6%2017-02-16, From 2014-01-01
2013-12-31$462.33M+16.6%2016-02-11, From 2013-01-01
2012-12-31$396.44M+14.8%2015-02-12, From 2012-01-01
2011-12-31$345.25Mn/a2014-02-13, From 2011-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Iqvia Holdings Inc. (IQV)2025-12-31$2.18B-0.9%
Icon PLC (ICLR)2025-12-31$442.85M-57.1%
Incyte Corp (INCY)2025-12-31$1.51Bn/m
Charles River Laboratories International, Inc. (CRL)2025-12-27$25.16M-88.9%
Medpace Holdings, Inc. (MEDP)2025-12-31$534.93M+19.7%
NRC Health (NRC)2025-12-31$22.59M-35.8%
MaxCyte, Inc. (MXCT)2025-12-31-$51.90Mn/m
OmniAb, Inc. (OABI)2025-12-31-$68.97Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$10.33Mn/m

Compare IQV, ICLR, INCY, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗